Th17 plasticity and its changes associated with inflammatory bowel disease

World Journal of Gastroenterology

Volumn 21, Issue 43, 2015, Pages 12283-12295

  Ueno, Aito ^a   Ghosh, Abhisek ^b   Hung, Daniel ^a   Li, Ji ^c   Jijon, Humberto ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b DARENT VALLEY HOSPITAL   (United Kingdom)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Inflammatory bowel disease; Regulatory T cells; T cell plasticity; Th7

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 6; KYNURENINE; MICRORNA; MICRORNA 210; RETINOIC ACID; STAT3 PROTEIN; STAT5 PROTEIN; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID; CYTOKINE;

ANKYLOSING SPONDYLITIS; ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CROHN DISEASE; CYTOKINE RELEASE; DISEASE ASSOCIATION; GENE EXPRESSION; GENETIC ASSOCIATION; HISTONE METHYLATION; HUMAN; IMMUNE DYSREGULATION; IMMUNE RESPONSE; LYMPHOCYTE SUBPOPULATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOGENESIS; PLASTICITY; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TH17 CELL; ULCERATIVE COLITIS; ANIMAL; CELL COMMUNICATION; CELL PLASTICITY; COLON; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; METABOLISM; PATHOLOGY; PHENOTYPE; TUMOR MICROENVIRONMENT;

ANIMALS; CELL COMMUNICATION; CELL PLASTICITY; CELLULAR MICROENVIRONMENT; COLON; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; PHENOTYPE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84948983885     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i43.12283     Document Type: Review

References (116)

1. Feldmann M, Maini SR. Role of cytokines in rheumatoid arthritis: An education in pathophysiology and therapeutics. Immunol Rev 2008; 223: 7-19 [PMID: 18613827 DOI: 10.1111/j.1600- 065X.2008.00626.x].
2. Damsker JM, Hansen AM, Caspi RR. Th1 and Th17 cells: Adversaries and collaborators. Ann N Y Acad Sci 2010; 1183: 211-221 [PMID: 20146717 DOI: 10.1111/j.1749-6632.2009.05133. x].
3. Kunz M, Ibrahim SM. Cytokines and cytokine profiles in human autoimmune diseases and animal models of autoimmunity. Mediators Inflamm 2009; 2009: 979258 [PMID: 19884985 DOI: 10.1155/2009/979258].
4. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol 2005; 175: 5-14 [PMID: 15972624].
5. Ahern PP, Izcue A, Maloy KJ, Powrie F. The interleukin-23 axis in intestinal inflammation. Immunol Rev 2008; 226: 147-159 [PMID: 19161422 DOI: 10.1111/j.1600-065X.2008.00705.x].
6. Annunziato F, Romagnani S. Do studies in humans better depict Th17 cells? Blood 2009; 114: 2213-2219 [PMID: 19494349 DOI: 10.1182/blood-2009-03-209189].
7. Chen Z, O'Shea JJ. Th17 cells: A new fate for differentiating helper T cells. Immunol Res 2008; 41: 87-102 [PMID: 18172584 DOI: 10.1007/s12026-007-8014-9].
8. Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M. Th17 cytokines and their emerging roles in inflammation and autoimmunity. Immunol Rev 2008; 226: 87-102 [PMID: 19161418 DOI: 10.1111/j.1600-065X.2008.00712.x].
9. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23 drives innate and T cellmediated intestinal inflammation. J Exp Med 2006; 203: 2473-2483 [PMID: 17030949].
10. Kullberg MC, Jankovic D, Feng CG, Hue S, Gorelick PL, McKenzie BS, Cua DJ, Powrie F, Cheever AW, Maloy KJ, Sher A. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med 2006; 203: 2485-2494 [PMID: 17030948].
11. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, Filler SG, Masso-Welch P, Edgerton M, Gaffen SL. Th17 cells and IL-17 recePTor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009; 206: 299-311 [PMID: 19204111 DOI: 10.1084/jem.20081463].
12. Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. IL-12 and IL-23: master regulators of innate and adaPTive immunity. Immunol Rev 2004; 202: 96-105 [PMID: 15546388].
13. Lin Y, Ritchea S, Logar A, Slight S, Messmer M, Rangel-Moreno J, Guglani L, Alcorn JF, Strawbridge H, Park SM, Onishi R, Nyugen N, Walter MJ, Pociask D, Randall TD, Gaffen SL, Iwakura Y, Kolls JK, Khader SA. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 2009; 31: 799-810 [PMID: 19853481 DOI: 10.1016/j.immuni.2009.08.025].
14. Maloy KJ, Kullberg MC. IL-23 and Th17 cytokines in intestinal homeostasis. Mucosal Immunol 2008; 1: 339-349 [PMID: 19079198 DOI: 10.1038/mi.2008.28].
15. O'Connor W, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 2009; 10: 603-609 [PMID: 19448631 DOI: 10.1038/ni.1736].
16. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol 2004; 110: 55-62 [PMID: 14962796 DOI: 10.1016/j.clim.2003.09.013].
17. Izcue A, Hue S, Buonocore S, Arancibia-Cárcamo CV, Ahern PP, Iwakura Y, Maloy KJ, Powrie F. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008; 28: 559-570 [PMID: 18400195 DOI: 10.1016/j.immuni.2008.02.019].
18. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, Elson CO, Weaver CT. Late developmental plasticity in the T helper 17 lineage. Immunity 2009; 30: 92-107 [PMID: 19119024 DOI: 10.1016/j.immuni.2008.11.005].
19. Rebhahn JA, Deng N, Sharma G, Livingstone AM, Huang S, Mosmann TR. An animated landscape representation of CD4+ T-cell differentiation, variability, and plasticity: insights into the behavior of populations versus cells. Eur J Immunol 2014; 44: 2216-2229 [PMID: 24945794 DOI: 10.1002/eji.201444645].
20. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, Cilley GE, Shen F, Eaton SM, Gaffen SL, Swain SL, Locksley RM, Haynes L, Randall TD, Cooper AM. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8: 369-377 [PMID: 17351619].
21. Harbour SN, Maynard CL, Zindl CL, Schoeb TR, Weaver CT. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc Natl Acad Sci USA 2015; 112: 7061-7066 [PMID: 26038559 DOI: 10.1073/pnas.1415675112].
22. Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 2008; 112: 2340-2352 [PMID: 18617638 DOI: 10.1182/blood-2008-01-133967].
23. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcriPTion factor Foxp3. Science 2003; 299: 1057-1061 [PMID: 12522256 DOI: 10.1126/science.1079490].
24. Makita S, Kanai T, Oshima S, Uraushihara K, Totsuka T, Sawada T, Nakamura T, Koganei K, Fukushima T, Watanabe M. CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells. J Immunol 2004; 173: 3119-3130 [PMID: 15322172].
25. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, Cheroutre H. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007; 317: 256-260 [PMID: 17569825].
26. Gratz IK, Campbell DJ. Organ-specific and memory tregcells: specificity, development, function, and maintenance. Front Immunol 2014; 5: 333 [PMID: 25076948 DOI: 10.3389/fimmu.2014.00333].
27. Fujino S, Andoh A, Bamba S, Ogawa A, Hata K, Araki Y, Bamba T, Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003; 52: 65-70 [PMID: 12477762].
28. Yang XO, Chang SH, Park H, Nurieva R, Shah B, Acero L, Wang YH, Schluns KS, Broaddus RR, Zhu Z, Dong C. Regulation of inflammatory responses by IL-17F. J Exp Med 2008; 205: 1063-1075 [PMID: 18411338 DOI: 10.1084/jem.20071978].
29. Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol 2010; 30: 196-203 [PMID: 20127275 DOI: 10.1007/s10875-010-9368-7].
30. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, Agarwal A, Huang W, Parkurst CN, Muratet M, Newberry KM, Meadows S, Greenfield A, Yang Y, Jain P, Kirigin FK, Birchmeier C, Wagner EF, Murphy KM, Myers RM, Bonneau R, Littman DR. A validated regulatory network for Th17 cell specification. Cell 2012; 151: 289-303 [PMID: 23021777 DOI: 10.1016/j.cell.2012.09.016].
31. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, BamPTon PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124 [PMID: 23128233 DOI: 10.1038/nature11582].
32. Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, Regev A, Kuchroo VK. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496: 513-517 [PMID: 23467085 DOI: 10.1038/nature11984].
33. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, Dang CV, Pardoll DM, Pan F. Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell 2011; 146: 772-784 [PMID: 21871655 DOI: 10.1016/j.cell.2011.07.033].
34. de Beaucoudrey L, Puel A, Filipe-Santos O, Cobat A, Ghandil P, Chrabieh M, Feinberg J, von Bernuth H, Samarina A, Jannière L, Fieschi C, Stéphan JL, Boileau C, Lyonnet S, Jondeau G, Cormier- Daire V, Le Merrer M, Hoarau C, Lebranchu Y, Lortholary O, Chandesris MO, Tron F, Gambineri E, Bianchi L, Rodriguez- Gallego C, Zitnik SE, Vasconcelos J, Guedes M, Vitor AB, Marodi L, Chapel H, Reid B, Roifman C, Nadal D, Reichenbach J, Caragol I, Garty BZ, Dogu F, Camcioglu Y, Gülle S, Sanal O, Fischer A, Abel L, Stockinger B, Picard C, Casanova JL. Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells. J Exp Med 2008; 205: 1543-1550 [PMID: 18591412 DOI: 10.1084/jem.20080321].
35. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, Cua DJ, Littman DR. The orphan nuclear recePTor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121-1133 [PMID: 16990136].
36. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006; 441: 235-238 [PMID: 16648838].
37. Mangan PR, Harrington LE, O'Quinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006; 441: 231-234 [PMID: 16648837].
38. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189 [PMID: 16473830].
39. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med 2006; 203: 1685-1691 [PMID: 16818675].
40. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L, Schluns K, Tian Q, Watowich SS, Jetten AM, Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480-483 [PMID: 17581589].
41. Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB. A largescale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007; 80: 273-290 [PMID: 17236132].
42. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ, Todd JA, Donnelly P, Barrett JC, Davison D, Easton D, Evans DM, Leung HT, Marchini JL, Morris AP, Spencer CC, Tobin MD, Attwood AP, Boorman JP, Cant B, Everson U, Hussey JM, Jolley JD, Knight AS, Koch K, Meech E, Nutland S, Prowse CV, Stevens HE, Taylor NC, Walters GR, Walker NM, Watkins NA, Winzer T, Jones RW, McArdle WL, Ring SM, Strachan DP, Pembrey M, Breen G, St Clair D, Caesar S, Gordon-Smith K, Jones L, Fraser C, Green EK, Grozeva D, Hamshere ML, Holmans PA, Jones IR, Kirov G, Moskivina V, Nikolov I, O'Donovan MC, Owen MJ, Collier DA, Elkin A, Farmer A, Williamson R, McGuffin P, Young AH, Ferrier IN, Ball SG, Balmforth AJ, Barrett JH, Bishop TD, Iles MM, Maqbool A, Yuldasheva N, Hall AS, Braund PS, Dixon RJ, Mangino M, Stevens S, Thompson JR, Bredin F, Tremelling M, Parkes M, Drummond H, Lees CW, Nimmo ER, Satsangi J, Fisher SA, Forbes A, Lewis CM, Onnie CM, Prescott NJ, Sanderson J, Matthew CG, Barbour J, Mohiuddin MK, Todhunter CE, Mansfield JC, Ahmad T, Cummings FR, Jewell DP, Webster J, Brown MJ, Lathrop MG, Connell J, Dominiczak A, Marcano CA, Burke B, Dobson R, Gungadoo J, Lee KL, Munroe PB, Newhouse SJ, Onipinla A, Wallace C, Xue M, Caulfield M, Farrall M, Barton A, Bruce IN, Donovan H, Eyre S, etal.Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007; 39: 1329-1337 [PMID: 17952073].
43. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature 2007; 447: 661-678 [PMID: 17554300].
44. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, Yang H, Targan S, Datta LW, Kistner EO, Schumm LP, Lee AT, Gregersen PK, Barmada MM, Rotter JI, Nicolae DL, Cho JH. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006; 314: 1461-1463 [PMID: 17068223].
45. Li LJ, Gong C, Zhao MH, Feng BS. Role of interleukin-22 in inflammatory bowel disease. World J Gastroenterol 2014; 20: 18177-18188 [PMID: 25561785 DOI: 10.3748/wjg.v20.i48.18177].
46. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, Karczewski J, Pezous N, Bek S, Bruin G, Mellgard B, Berger C, Londei M, Bertolino AP, Tougas G, Travis SP. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012; 61: 1693-1700 [PMID: 22595313 DOI: 10.1136/gutjnl-2011-301668].
47. O'Shea JJ, Kanno Y, Chan AC. In search of magic bullets: The golden age of immunotherapeutics. Cell 2014; 157: 227-240 [PMID: 24679538 DOI: 10.1016/j.cell.2014.03.010].
48. Josefowicz SZ, Lu LF, Rudensky AY. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 2012; 30: 531-564 [PMID: 22224781 DOI: 10.1146/annurev. immunol.25.022106.141623].
49. Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH. Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 2007; 179: 3724-3733 [PMID: 17785809].
50. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008; 453: 236-240 [PMID: 18368049 DOI: 10.1038/nature06878].
51. Yang KL, Chang WT, Hung KC, Li EI, Chuang CC. Inhibition of transforming growth factor-beta-induced liver fibrosis by a retinoic acid derivative via the suppression of Col 1A2 promoter activity. Biochem Biophys Res Commun 2008; 373: 219-223 [PMID: 18558083 DOI: 10.1016/j.bbrc.2008.05.192].
52. Martinez GJ, Zhang Z, Reynolds JM, Tanaka S, Chung Y, Liu T, Robertson E, Lin X, Feng XH, Dong C. Smad2 positively regulates the generation of Th17 cells. J Biol Chem 2010; 285: 29039-29043 [PMID: 20667820 DOI: 10.1074/jbc.C110.155820].
53. Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, Laufer TM, Ignatowicz L, Ivanov II. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 2014; 40: 594-607 [PMID: 24684957 DOI: 10.1016/j.immuni.2014.03.005].
54. Atarashi K, Tanoue T, Oshima K, Suda W, Nagano Y, Nishikawa H, Fukuda S, Saito T, Narushima S, Hase K, Kim S, Fritz JV, Wilmes P, Ueha S, Matsushima K, Ohno H, Olle B, Sakaguchi S, Taniguchi T, Morita H, Hattori M, Honda K. Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013; 500: 232-236 [PMID: 23842501 DOI: 10.1038/nature12331].
55. Geuking MB, Cahenzli J, Lawson MA, Ng DC, Slack E, Hapfelmeier S, McCoy KD, Macpherson AJ. Intestinal bacterial colonization induces mutualistic regulatory T cell responses. Immunity 2011; 34: 794-806 [PMID: 21596591 DOI: 10.1016/j.immuni.2011.03.021].
56. Livingston M, Loach D, Wilson M, Tannock GW, Baird M. Gut commensal Lactobacillus reuteri 100-23 stimulates an immunoregulatory response. Immunol Cell Biol 2010; 88: 99-102 [PMID: 19786979 DOI: 10.1038/icb.2009.71].
57. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V. Activation of Gpr109a, recePTor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014; 40: 128-139 [PMID: 24412617 DOI: 10.1016/j.immuni.2013.12.007].
58. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 2013; 504: 451-455 [PMID: 24226773 DOI: 10.1038/nature12726].
59. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like recePTor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011; 332: 974-977 [PMID: 21512004 DOI: 10.1126/science.1206095].
60. Ueno A, Jijon H, Chan R, Ford K, Hirota C, Kaplan GG, Beck PL, Iacucci M, Fort Gasia M, Barkema HW, Panaccione R, Ghosh S. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19: 2522-2534 [PMID: 24097227 DOI: 10.1097/MIB.0b013e3182a85709].
61. Basu R, Whitley SK, Bhaumik S, Zindl CL, Schoeb TR, Benveniste EN, Pear WS, Hatton RD, Weaver CT. IL-1 signaling modulates activation of STAT transcriPTion factors to antagonize retinoic acid signaling and control the TH17 cell-iTreg cell balance. Nat Immunol 2015; 16: 286-295 [PMID: 25642823 DOI: 10.1038/ni.3099].
62. Zhang L, Yuan S, Cheng G, Guo B. Type I IFN promotes IL-10 production from T cells to suppress Th17 cells and Th17-associated autoimmune inflammation. PLoS One 2011; 6: e28432 [PMID: 22163016 DOI: 10.1371/journal.pone.0028432].
63. Yang L, Anderson DE, Baecher-Allan C, Hastings WD, Bettelli E, Oukka M, Kuchroo VK, Hafler DA. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 2008; 454: 350-352 [PMID: 18469800 DOI: 10.1038/nature07021].
64. Fantini MC, Rizzo A, Fina D, Caruso R, Becker C, Neurath MF, Macdonald TT, Pallone F, Monteleone G. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells. Eur J Immunol 2007; 37: 3155-3163 [PMID: 17918200 DOI: 10.1002/eji.200737766].
65. Peluso I, Fantini MC, Fina D, Caruso R, Boirivant M, MacDonald TT, Pallone F, Monteleone G. IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes. J Immunol 2007; 178: 732-739 [PMID: 17202333].
66. Sugimoto K, Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 2008; 118: 534-544 [PMID: 18172556 DOI: 10.1172/JCI33194].
67. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Stevens S, Flavell RA. Innate and adaPTive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008; 29: 947-957 [PMID: 19100701 DOI: 10.1016/j.immuni.2008.11.003].
68. Awasthi A, Riol-Blanco L, Jäger A, Korn T, Pot C, Galileos G, Bettelli E, Kuchroo VK, Oukka M. Cutting edge: IL-23 recePTor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 2009; 182: 5904-5908 [PMID: 19414740 DOI: 10.4049/jimmunol.0900732].
69. Coccia M, Harrison OJ, Schiering C, Asquith MJ, Becher B, Powrie F, Maloy KJ. IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J Exp Med 2012; 209: 1595-1609 [PMID: 22891275 DOI: 10.1084/jem.20111453].
70. Mudter J, Yu J, Zufferey C, Brüstle A, Wirtz S, Weigmann B, Hoffman A, Schenk M, Galle PR, Lehr HA, Mueller C, Lohoff M, Neurath MF. IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo. Inflamm Bowel Dis 2011; 17: 1343-1358 [PMID: 21305677 DOI: 10.1002/ibd.21476].
71. Huber M, Lohoff M. IRF4 at the crossroads of effector T-cell fate decision. Eur J Immunol 2014; 44: 1886-1895 [PMID: 24782159 DOI: 10.1002/eji.201344279].
72. Vasanthakumar A, Moro K, Xin A, Liao Y, Gloury R, Kawamoto S, Fagarasan S, Mielke LA, Afshar-Sterle S, Masters SL, Nakae S, Saito H, Wentworth JM, Li P, Liao W, Leonard WJ, Smyth GK, Shi W, Nutt SL, Koyasu S, Kallies A. The transcriPTional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells. Nat Immunol 2015; 16: 276-285 [PMID: 25599561 DOI: 10.1038/ni.3085].
73. Punkenburg E, Vogler T, Büttner M, Amann K, Waldner M, Atreya R, Abendroth B, Mudter J, Merkel S, Gallmeier E, Rose- John S, Neurath MF, Hildner K. Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer. Gut 2015; Epub ahead of print [PMID: 25838550].
74. Quintana FJ, Jin H, Burns EJ, Nadeau M, Yeste A, Kumar D, Rangachari M, Zhu C, Xiao S, Seavitt J, Georgopoulos K, Kuchroo VK. Aiolos promotes TH17 differentiation by directly silencing Il2 expression. Nat Immunol 2012; 13: 770-777 [PMID: 22751139 DOI: 10.1038/ni.2363].
75. Raffin C, Pignon P, Celse C, Debien E, Valmori D, Ayyoub M. Human memory Helios- FOXP3+ regulatory T cells (Tregs) encompass induced Tregs that express Aiolos and respond to IL- 1β by downregulating their suppressor functions. J Immunol 2013; 191: 4619-4627 [PMID: 24068664 DOI: 10.4049/jimmunol.1301378].
76. Liu HP, Cao AT, Feng T, Li Q, Zhang W, Yao S, Dann SM, Elson CO, Cong Y. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression. Eur J Immunol 2015; 45: 1010-1018 [PMID: 25605286 DOI: 10.1002/eji.201444726].
77. Nakayamada S, Takahashi H, Kanno Y, O'Shea JJ. Helper T cell diversity and plasticity. Curr Opin Immunol 2012; 24: 297-302 [PMID: 22341735 DOI: 10.1016/j.coi.2012.01.014].
78. Baumjohann D, Ansel KM. MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 2013; 13: 666-678 [PMID: 23907446 DOI: 10.1038/nri3494].
79. O'Neill LA, Sheedy FJ, McCoy CE. MicroRNAs: The finetuners of Toll-like recePTor signalling. Nat Rev Immunol 2011; 11: 163-175 [PMID: 21331081 DOI: 10.1038/nri2957].
80. Brain O, Owens BM, Pichulik T, Allan P, Khatamzas E, Leslie A, Steevels T, Sharma S, Mayer A, Catuneanu AM, Morton V, Sun MY, Jewell D, Coccia M, Harrison O, Maloy K, Schönefeldt S, Bornschein S, Liston A, Simmons A. The intracellular sensor NOD2 induces microRNA-29 expression in human dendritic cells to limit IL-23 release. Immunity 2013; 39: 521-536 [PMID: 24054330 DOI: 10.1016/j.immuni.2013.08.035].
81. Wang H, Flach H, Onizawa M, Wei L, McManus MT, Weiss A. Negative regulation of Hif1a expression and TH17 differentiation by the hypoxia-regulated microRNA miR-210. Nat Immunol 2014; 15: 393-401 [PMID: 24608041 DOI: 10.1038/ni.2846].
82. Nakahama T, Hanieh H, Nguyen NT, Chinen I, Ripley B, Millrine D, Lee S, Nyati KK, Dubey PK, Chowdhury K, Kawahara Y, Kishimoto T. Aryl hydrocarbon recePTor-mediated induction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation. Proc Natl Acad Sci USA 2013; 110: 11964-11969 [PMID: 23818645 DOI: 10.1073/pnas.1311087110].
83. Kroesen BJ, Teteloshvili N, Smigielska-Czepiel K, Brouwer E, Boots AM, van den Berg A, Kluiver J. Immuno-miRs: critical regulators of T-cell development, function and ageing. Immunology 2015; 144: 1-10 [PMID: 25093579 DOI: 10.1111/imm.12367].
84. Kouri RR, Ratrie H, Atlas SA, Niwa A, Nebert DW. Aryl hydrocarbon hydroxylase induction in human lymphocyte cultures by 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin. Life Sci 1974; 15: 1585-1595 [PMID: 4549995].
85. Mason ME, Okey AB. Aryl hydrocarbon hydroxylase activity in mouse, rat, and human mammary tumors. Cancer Res 1981; 41: 2778-2782 [PMID: 6265068].
86. Okey AB, Riddick DS, Harper PA. The Ah recePTor: mediator of the toxicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. Toxicol Lett 1994; 70: 1-22 [PMID: 8310450].
87. Marshall NB, Kerkvliet NI. Dioxin and immune regulation: emerging role of aryl hydrocarbon recePTor in the generation of regulatory T cells. Ann N Y Acad Sci 2010; 1183: 25-37 [PMID: 20146706 DOI: 10.1111/j.1749-6632.2009.05125.x].
88. Esser C, Rannug A, Stockinger B. The aryl hydrocarbon recePTor in immunity. Trends Immunol 2009; 30: 447-454 [PMID: 19699679 DOI: 10.1016/j.it.2009.06.005].
89. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon recePTor. Nature 2008; 453: 65-71 [PMID: 18362915 DOI: 10.1038/nature06880].
90. Veldhoen M, Hirota K, Westendorf AM, Buer J, Dumoutier L, Renauld JC, Stockinger B. The aryl hydrocarbon recePTor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008; 453: 106-109 [PMID: 18362914 DOI: 10.1038/nature06881].
91. Kimura A, Naka T, Nohara K, Fujii-Kuriyama Y, Kishimoto T. Aryl hydrocarbon recePTor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 2008; 105: 9721-9726 [PMID: 18607004 DOI: 10.1073/pnas.0804231105].
92. Veldhoen M, Hirota K, Christensen J, O'Garra A, Stockinger B. Natural agonists for aryl hydrocarbon recePTor in culture medium are essential for oPTimal differentiation of Th17 T cells. J Exp Med 2009; 206: 43-49 [PMID: 19114668 DOI: 10.1084/jem.20081438].
93. Hauben E, Gregori S, Draghici E, Migliavacca B, Olivieri S, Woisetschläger M, Roncarolo MG. Activation of the aryl hydrocarbon recePTor promotes allograft-specific tolerance through direct and dendritic cell-mediated effects on regulatory T cells. Blood 2008; 112: 1214-1222 [PMID: 18550851 DOI: 10.1182/blood-2007-08-109843].
94. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon recePTor can generate regulatory T cells. J Immunol 2010; 185: 3190-3198 [PMID: 20720200 DOI: 10.4049/jimmunol.0903670].
95. Nguyen NT, Nakahama T, Le DH, Van Son L, Chu HH, Kishimoto T. Aryl hydrocarbon recePTor and kynurenine: recent advances in autoimmune disease research. Front Immunol 2014; 5: 551 [PMID: 25400638 DOI: 10.3389/fimmu.2014.00551].
96. Moura-Alves P, Faé K, Houthuys E, Dorhoi A, Kreuchwig A, Furkert J, Barison N, Diehl A, Munder A, Constant P, Skrahina T, Guhlich-Bornhof U, Klemm M, Koehler AB, Bandermann S, Goosmann C, Mollenkopf HJ, Hurwitz R, Brinkmann V, Fillatreau S, Daffe M, Tümmler B, Kolbe M, Oschkinat H, Krause G, Kaufmann SH. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 2014; 512: 387-392 [PMID: 25119038 DOI: 10.1038/nature13684].
97. Lee BM, Mahadevan LC. Stability of histone modifications across mammalian genomes: implications for 'epigenetic' marking. J Cell Biochem 2009; 108: 22-34 [PMID: 19623574 DOI: 10.1002/jcb.22250].
98. Wei G, Wei L, Zhu J, Zang C, Hu-Li J, Yao Z, Cui K, Kanno Y, Roh TY, Watford WT, Schones DE, Peng W, Sun HW, Paul WE, O'Shea JJ, Zhao K. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 2009; 30: 155-167 [PMID: 19144320 DOI: 10.1016/j.immuni.2008.12.009].
99. Rowell E, Wilson CB. Programming perpetual T helper cell plasticity. Immunity 2009; 30: 7-9 [PMID: 19144312 DOI: 10.1016/j.immuni.2008.12.012].
100. Xiang Y, Zhu Z, Han G, Lin H, Xu L, Chen CD. JMJD3 is a histone H3K27 demethylase. Cell Res 2007; 17: 850-857 [PMID: 17923864].
101. Li Q, Zou J, Wang M, Ding X, Chepelev I, Zhou X, Zhao W, Wei G, Cui J, Zhao K, Wang HY, Wang RF. Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation. Nat Commun 2014; 5: 5780 [PMID: 25531312 DOI: 10.1038/ncomms6780].
102. Esposito M, Ruffini F, Bergami A, Garzetti L, Borsellino G, Battistini L, Martino G, Furlan R. IL-17- And IFN-γ-secreting Foxp3+ T cells infiltrate the target tissue in experimental autoimmunity. J Immunol 2010; 185: 7467-7473 [PMID: 21098230 DOI: 10.4049/jimmunol.1001519].
103. Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity 2009; 30: 646-655 [PMID: 19464987 DOI: 10.1016/j.immuni.2009.05.001].
104. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, de Jager W, Evans JG, Cimaz R, Bajaj-Elliott M, Wedderburn LR. Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci USA 2010; 107: 14751-14756 [PMID: 20679229 DOI: 10.1073/pnas.1003852107].
105. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol 2009; 27: 485-517 [PMID: 19132915 DOI: 10.1146/annurev.immunol.021908.132710].
106. Globig AM, Hennecke N, Martin B, Seidl M, Ruf G, Hasselblatt P, Thimme R, Bengsch B. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL- 17+coproducing CD4+ T cells in active inflammatory bowel disease. Inflamm Bowel Dis 2014; 20: 2321-2329 [PMID: 25248005 DOI: 10.1097/MIB.0000000000000210].
107. Singh K, Gatzka M, Peters T, Borkner L, Hainzl A, Wang H, Sindrilaru A, Scharffetter-Kochanek K. Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis. J Immunol 2013; 190: 2544-2553 [PMID: 23418628 DOI: 10.4049/jimmunol.1202399].
108. Gagliani N, Vesely MC, Iseppon A, Brockmann L, Xu H, Palm NW, de Zoete MR, Licona-Limón P, Paiva RS, Ching T, Weaver C, Zi X, Pan X, Fan R, Garmire LX, Cotton MJ, Drier Y, Bernstein B, Geginat J, Stockinger B, Esplugues E, Huber S, Flavell RA. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 2015; 523: 221-225 [PMID: 25924064 DOI: 10.1038/nature14452].
109. Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009; 31: 401-411 [PMID: 19766083 DOI: 10.1016/j.immuni.2009.08.011].
110. Morrison PJ, Ballantyne SJ, Kullberg MC. Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity. Immunology 2011; 133: 397-408 [PMID: 21631495 DOI: 10.1111/j.1365-2567.2011.03454.x].
111. Hovhannisyan Z, Treatman J, Littman DR, Mayer L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 2011; 140: 957-965 [PMID: 21147109 DOI: 10.1053/j.gastro.2010.12.002].
112. Li J, Ueno A, Fort Gasia M, Hirota C, Deane M, Chan R, Iacucci M, Kaplan G, Panaccione R, Luider J, Wang T, Tom M, Qian JM, Gui X, Ghosh S. Distinctive Th17 Lymphocyte Plasticity in Intestinal Lamina Propria of IBD Patients Compared With Healthy Controls. Gastoroenterology 2015; 148: S323 [DOI: 10.1016/S0016-5085(15)31070-2].
113. Eisenstein EM, Williams CB. The T(reg)/Th17 cell balance: A new paradigm for autoimmunity. Pediatr Res 2009; 65: 26R-31R [PMID: 19218879 DOI: 10.1203/PDR.0b013e31819e76c7].
114. Desreumaux P, Foussat A, Allez M, Beaugerie L, Hébuterne X, Bouhnik Y, Nachury M, Brun V, Bastian H, Belmonte N, Ticchioni M, Duchange A, Morel-Mandrino P, Neveu V, Clerget-Chossat N, Forte M, Colombel JF. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease. Gastroenterology 2012; 143: 1207-1217.e1-e2 [PMID: 22885333 DOI: 10.1053/j.gastro.2012.07.116].
115. Brüstle A, Heink S, Huber M, Rosenplänter C, Stadelmann C, Yu P, Arpaia E, Mak TW, Kamradt T, Lohoff M. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8: 958-966 [PMID: 17676043].
116. Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B, Sahota G, Sim J, Mukasa R, Cemerski S, Hatton RD, Stormo GD, Weaver CT, Russell JH, Murphy TL, Murphy KM. The AP-1 transcriPTion factor Batf controls T(H)17 differentiation. Nature 2009; 460: 405-409 [PMID: 19578362 DOI: 10.1038/nature08114].